Endometrial hyperplasia natural history, complications and prognosis

Jump to navigation Jump to search

Endometrial hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Endometrial hyperplasia natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial hyperplasia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial hyperplasia natural history, complications and prognosis

CDC on Endometrial hyperplasia natural history, complications and prognosis

Endometrial hyperplasia natural history, complications and prognosis in the news

Blogs on Endometrial hyperplasia natural history, complications and prognosis

Directions to Hospitals Treating Endometrial hyperplasia

Risk calculators and risk factors for Endometrial hyperplasia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]

Overview

The majority of cases of endometrial hyperplasia (except complex atypical hyperplasia) resolve spontaneously with time.[1] If left untreated, 30% of patients with atypical hyperplasia may progress to develop endometrial carcinoma.[2] Malignant transformation into endometrial cancer is the most common complication of endometrial hyperpasia.[3] Prognosis is generally good with treatment.

Natural History

  • The majority of cases of endometrial hyperplasia (except complex atypical hyperplasia) resolve spontaneously with time.[1]
  • If left untreated, 30% of patients with atypical hyperplasia may progress to develop endometrial carcinoma.[2]


Hyperplasia without atypia tends to spontaneously regress.

  • whereas atypical hyperplasias are more likely to progress Terakawa N, Kigawa J, Taketani Y, Yoshikawa H, Yajima A, Noda K, Okada H, Kato J, Yakushiji M, Tanizawa O, Fujimoto S, Nozawa S, Takahashi T, Hasumi K, Furuhashi N, Aono T, Sakamoto A, Furusato M (June 1997). "The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group". J. Obstet. Gynaecol. Res. 23 (3): 223–30. PMID 9255033.
  • Endometrial carcinoma with concomitant hyperplasia is associated with less aggressive disease.
When an endometrial biopsy or curettage specimen is diagnosed as atypical hyperplasia, the risk of concomitant carcinoma in the same uterus has been reported as 17% to 25% (35–37). However, 2 recent studies have concluded that the concomitant presence of carcinoma in uteri sampled for endometrial hyperplasia is considerably higher.[4]

Complications

Malignant transformation is the most common complication of endometrial hyperpasia.[3]

Complications of untreated or poorly controlled endometrial hyperplasia can be serious. You can help minimize your risk of serious complications by following the treatment plan you and your health care professional design specifically for you. Complications of endometrial hyperplasia include:
   Absenteeism from work or school
   Anemia (low red blood cell count)
   Cancer of the uterus
   Inability to participate normally in activities
   Infertility
   Menorrhagia (heavy bleeding during your menstrual period)

Prognosis

Prognosis is generally good with treatment for endometrial hyperplasias without atypia.

References

  1. 1.0 1.1 Terakawa N, Kigawa J, Taketani Y, Yoshikawa H, Yajima A, Noda K; et al. (1997). "The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group". J Obstet Gynaecol Res. 23 (3): 223–30. PMID 9255033.
  2. 2.0 2.1 Lacey JV, Chia VM (2009). "Endometrial hyperplasia and the risk of progression to carcinoma". Maturitas. 63 (1): 39–44. doi:10.1016/j.maturitas.2009.02.005. PMID 19285814.
  3. 3.0 3.1 Endometrial hyperplasia. Radiopedia. http://radiopaedia.org/articles/endometrial-hyperplasia-1 Accessed on March 16, 2016
  4. Widra, E.A.; Dunton, C.J.; McHugh, M.; Palazzo, J.P. (1995). "Endometrial hyperplasia and the risk of carcinoma". International Journal of Gynecological Cancer. 5 (3): 233–235. doi:10.1046/j.1525-1438.1995.05030233.x. ISSN 1048-891X.

Template:WikiDoc Sources